MEET THE TEAM
The ClinSpec Dx™ team have a strong track record in scientific achievement and successful commercial realisation.
Professor Steven Howell
Highly experienced Chair and serial entrepreneur, having commercialised 10 products in diagnostics and healthcare. Formerly held senior positions in Alere and Inverness Medical.
Dr Stephen Little
Strong track record as a diagnostics leader. Former Founder & CEO of DxS (sold to Qiagen for $130M), former R&D Manager Astra Zeneca Diagnostics, and current Vice Chairman at Yourgene Health.
Dr Matthew J Baker
CHIEF TECHNOLOGY OFFICER
Inventor with 15+ years’ experience in the field of clinical spectroscopy in the MoD and Academia.
Emerging Leader In Molecular Spectroscopy, 2016, and Harrison-Meldola Medal winner, Royal Society of Chemistry, 2017.
Dr Holly J Butler
HEAD OF DEVELOPMENT
8+ years experience in the clinical spectroscopy field.
'Young Entrepreneur' of the year winner, 2017 – Scottish Women's Awards
'Women in Innovation' winner, 2017 – Global Game Changers Awards
Experienced post doc researcher in biophotonics and infrared analysis.
Dr Mark Hegarty
CHIEF EXECUTIVE OFFICER
20+ years experience in startups and healthcare products, successfully building international B2B sales and relationships across 20+ countries.
Previously led Daysoft Limited from zero to £10m sales per annum, realising an initial £3m return to investors and creating 220 jobs.
Dr David S Palmer
CHIEF DATA SCIENTIST
15+ years experience in the field of data analysis and machine learning. Computational chemist, leading the design and development of the ClinSpec Dx diagnostic algorithms. Marie Curie Research Fellowship holder.